DrugPatentWatch Database Preview
Horizon Therap Company Profile
Email this page to a colleague
What is the competitive landscape for HORIZON THERAP, and what generic alternatives to HORIZON THERAP drugs are available?
HORIZON THERAP has three approved drugs.
There are sixteen US patents protecting HORIZON THERAP drugs.
There are ninety-three patent family members on HORIZON THERAP drugs in twenty-nine countries and seventy-four supplementary protection certificates in sixteen countries.
Summary for Horizon Therap
| International Patents: | 93 |
| US Patents: | 16 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
| PTAB Cases with Horizon Therap as patent owner: | See PTAB cases with Horizon Therap as patent owner |
Drugs and US Patents for Horizon Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | AA | RX | Yes | Yes | 10,045,958 | ⤷ Try it Free | ⤷ Try it Free | |||
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | AA | RX | Yes | Yes | 9,095,559 | ⤷ Try it Free | ⤷ Try it Free | |||
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | AA | RX | Yes | Yes | 10,183,006 | ⤷ Try it Free | ⤷ Try it Free | |||
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | AA | RX | Yes | Yes | 10,183,005 | ⤷ Try it Free | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Horizon Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Horizon Therap | BUPHENYL | sodium phenylbutyrate | POWDER;ORAL | 020573-001 | Apr 30, 1996 | 4,457,942 | ⤷ Try it Free |
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | 5,968,979 | ⤷ Try it Free |
| Horizon Therap | BUPHENYL | sodium phenylbutyrate | TABLET;ORAL | 020572-001 | May 13, 1996 | 4,457,942 | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HORIZON THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Oral Liquid | 1.1 g/mL | ➤ Subscribe | 2013-11-19 |
International Patents for Horizon Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 365302 | ⤷ Try it Free |
| Ecuador | SP14024561 | ⤷ Try it Free |
| Serbia | 55870 | ⤷ Try it Free |
| Spain | 2629859 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Horizon Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2330892 | 2016023 | Norway | ⤷ Try it Free | PRODUCT NAME: GLYCEROLFENYLBUTYRAT; REG. NO/DATE: EU/1/15/1062 20151210 |
| 2673237 | LUC00111 | Luxembourg | ⤷ Try it Free | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326 |
| 2203431 | CA 2015 00014 | Denmark | ⤷ Try it Free | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115 |
| 2330892 | 2016C/074 | Belgium | ⤷ Try it Free | PRODUCT NAME: GLYCEROLFENYLBUTYRAAT; AUTHORISATION NUMBER AND DATE: EU/1/15/1062 20151201 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
